| Anticancer potential of alkaloids: a key emphasis to colchicine, vinblastine, vincristine, vindesine, vinorelbine and vincamine P Dhyani, C Quispe, E Sharma, A Bahukhandi, P Sati, DC Attri, A Szopa, ... Cancer cell international 22 (1), 206, 2022 | 185 | 2022 |
| COVID-19 pandemic and alcohol consumption: Impacts and interconnections D Calina, T Hartung, I Mardare, M Mitroi, K Poulas, A Tsatsakis, ... Toxicology reports 8, 529-535, 2021 | 173 | 2021 |
| The implementation of managed entry agreements in Central and Eastern Europe: findings and implications A Ferrario, D Arāja, T Bochenek, T Čatić, D Dankó, M Dimitrova, J Fürst, ... Pharmacoeconomics 35, 1271-1285, 2017 | 161 | 2017 |
| Barriers for access to new medicines: searching for the balance between rising costs and limited budgets B Godman, A Bucsics, P Vella Bonanno, W Oortwijn, CC Rothe, A Ferrario, ... Frontiers in Public Health 6, 328, 2018 | 152 | 2018 |
| Fixed dose drug combinations–are they pharmacoeconomically sound? Findings and implications especially for lower-and middle-income countries B Godman, H McCabe, T D Leong, D Mueller, AP Martin, I Hoxha, ... Expert review of pharmacoeconomics & outcomes research 20 (1), 1-26, 2020 | 81 | 2020 |
| Potential approaches for the pricing of cancer medicines across Europe to enhance the sustainability of healthcare systems and the implications B Godman, A Hill, S Simoens, G Selke, I Selke Krulichová, ... Expert review of pharmacoeconomics & outcomes research 21 (4), 527-540, 2021 | 65 | 2021 |
| The Expiry of Humira® Market Exclusivity and the Entry of Adalimumab Biosimilars in Europe: An Overview of Pricing and National Policy Measures E Moorkens, B Godman, I Huys, I Hoxha, A Malaj, S Keuerleber, ... Frontiers in pharmacology 11, 591134, 2021 | 65 | 2021 |
| Adaptive pathways: possible next steps for payers in preparation for their potential implementation P Vella Bonanno, M Ermisch, B Godman, AP Martin, J Van Den Bergh, ... Frontiers in pharmacology 8, 497, 2017 | 53 | 2017 |
| Pricing of oral generic cancer medicines in 25 European countries; findings and implications B Godman, A Hill, S Simoens, A Kurdi, J Gulbinovič, A Martin, A Timoney, ... Generics and Biosimilars Initiative Journal 8 (2), 49-70, 2019 | 50 | 2019 |
| Proposal for a regulation on health technology assessment in Europe–opinions of policy makers, payers and academics from the field of HTA P Vella Bonanno, A Bucsics, S Simoens, AP Martin, W Oortwijn, ... Expert review of pharmacoeconomics & outcomes research 19 (3), 251-261, 2019 | 44 | 2019 |
| Evidence-based public policy making for medicines across countries: findings and implications for the future B Godman, J Fadare, HY Kwon, CZ Dias, A Kurdi, IP Dias Godoi, ... Journal of comparative effectiveness research 10 (12), 1019-1052, 2021 | 43 | 2021 |
| The current situation regarding long-acting insulin analogues including biosimilars among African, Asian, European, and South American countries; findings and implications for … B Godman, M Haque, T Leong, E Allocati, S Kumar, S Islam, J Charan, ... Frontiers in public health 9, 671961, 2021 | 37 | 2021 |
| Time to review authorisation and funding for new cancer medicines in Europe? Inferences from the case of Olaratumab C Pontes, C Zara, J Torrent-Farnell, M Obach, C Nadal, P Vella-Bonanno, ... Applied health economics and health policy 18, 5-16, 2020 | 37 | 2020 |
| Therapeutic strategies for rheumatic diseases and disorders: targeting redox imbalance and oxidative stress MT Islam, C Sarkar, R Hossain, MS Bhuia, I Mardare, M Kulbayeva, ... Biomedicine & Pharmacotherapy 164, 114900, 2023 | 12 | 2023 |
| Challenges and opportunities with routinely collected data on the utilization of cancer medicines. Perspectives from health authority personnel across 18 European Countries A Pisana, B Wettermark, A Kurdi, B Tubic, C Pontes, C Zara, E Van Ganse, ... Frontiers in pharmacology 13, 873556, 2022 | 10 | 2022 |
| Utilisation trend of long-acting insulin analogues including biosimilars across Europe: findings and implications B Godman, M Wladysiuk, S McTaggart, A Kurdi, E Allocati, M Jakovljevic, ... BioMed research international 2021, 2021 | 8 | 2021 |
| Quality of life in parents of autistic children: A transcultural perspective V Eapen, L Karlov, JR John, C Beneytez, PZ Grimes, YQ Kang, I Mardare, ... Frontiers in psychology 14, 1022094, 2023 | 7 | 2023 |
| Variation in the prices of oncology medicines across Europe and the implications for the future B Godman, S Simoens, A Kurdi, G Selke, J Yfantopoulos, A Hill, ... Generics and Biosimilars Initiative Journal 10 (2), 72-82, 2021 | 7 | 2021 |
| Measuring health related quality of life-methods and tools I Mardare, FL Furtunescu, EC Bratu Acta Medica Transilvanica 24 (2), 6-8, 2019 | 7 | 2019 |
| Pricing and reimbursement of patent-protected medicines: challenges and lessons from South-Eastern Europe L Vončina, T Strbad, J Fürst, M Dimitrova, M Kamusheva, M Vila, ... Applied health economics and health policy 19, 915-927, 2021 | 6 | 2021 |
